Detalhe da pesquisa
1.
Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection.
Clin Infect Dis
; 76(3): e553-e560, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36136811
2.
Prevalence, incidence and recurrence of sexually transmitted infections in HIV-negative adult women in a rural South African setting.
Trop Med Int Health
; 28(4): 335-342, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852895
3.
Unmasking a silent killer: Prevalence of diagnosed and undiagnosed diabetes mellitus among people living with HIV in rural South Africa.
Trop Med Int Health
; 28(5): 367-373, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920286
4.
Predictors of Treatment Adherence and Virological Failure Among People Living with HIV Receiving Antiretroviral Therapy in a South African Rural Community: A Sub-study of the ITREMA Randomised Clinical Trial.
AIDS Behav
; 27(12): 3863-3885, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382825
5.
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
PLoS Med
; 17(2): e1003037, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32097428
6.
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
BMC Infect Dis
; 18(1): 251, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859062
7.
Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa.
S Afr J Infect Dis
; 38(1): 550, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223432
8.
HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment.
AIDS
; 36(7): 923-931, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113046
9.
A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch.
AIDS
; 36(14): 1959-1968, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950949
10.
Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study.
J Acquir Immune Defic Syndr
; 87(4): 1072-1078, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153013
11.
Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa.
J Int AIDS Soc
; 24 Suppl 6: e25802, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713545
12.
Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries.
AIDS
; 34(9): 1261-1288, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32287056
13.
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART.
J Int AIDS Soc
; 23(6): e25501, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515898
14.
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.
Sci Rep
; 10(1): 15866, 2020 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32985522
15.
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
Lancet Infect Dis
; 18(2): 188-197, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158101